Induced Pluripotent Stem Cell Market 2020: Global Size, Growth, Demand, Opportunities and Forecast To 2030 | COVID-19 Impact Analysis

The Business Research Company offers "Induced Pluripotent Stem Cell (IPSC) Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global induced pluripotent stem cell (ipsc) market is expected to grow from $2.2 billion in 2019 to $2.5 billion in 2020 at a compound annual growth rate (CAGR) of 12.6%. The growth of this market is due to increased spending of companies on the research and development pertaining to life sciences. The market is then expected to recover and grow at a CAGR of 9.3% from 2021 and reach $3.2 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2515

The induced pluripotent stem cell (iPSC) market consists of sales of induced pluripotent stem cells and related services. Induced pluripotent stem cells are the regenerated form of stem cells, which are produced from an existing adult cell, such as from hepatocytes, fibroblasts, keratinocytes and neurons.

Increase in the prevalence of chronic disorders is one of the major factors that is driving the growth of Induced pluripotent stem cell market. Chronic disorders like heart disease, cancer, stroke, diabetes can be treated with Induced pluripotent stem cell. Induced Pluripotent stem cells are taken from any tissues from a child or an adult and are genetically modified to behave like embryonic stem cells. According to the report published by Partnership to Fight Chronic Disorder (PFCD) in 2018, it was found that out of 133 Million Americans, 45% of the population had at least one chronic disorder. Moreover, it was estimated that 7 out of 10 deaths in the USA, which is approximately 1.7 million, are due to chronic disorders and these deaths can be controlled by induced pluripotent stem cell treatment. This rise in incidences of chronic diseases is driving the demand for induced pluripotent stem cell treatment.

Induced Pluripotent Stem Cell Market Segmentation: -
By Derived Cell Type
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others

By Application
Academic Research
Drug Development And Discovery
Toxicity Screening
Regenerative Medicine

By End-User
Hospitals
Research Laboratories

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/induced-pluripotent-stem-cell-ipsc-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Induced Pluripotent Stem Cell Market Characteristics
3. Induced Pluripotent Stem Cell Market Size And Growth
4. Induced Pluripotent Stem Cell Market Segmentation
5. Induced Pluripotent Stem Cell Market Regional And Country Analysis
.....
25. Induced Pluripotent Stem Cell Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Induced Pluripotent Stem Cell Market
27. Induced Pluripotent Stem Cell Market Trends And Strategies
28. Induced Pluripotent Stem Cell Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the Induced Pluripotent Stem Cell Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2515&type=smp

Some of the key players involved in the Induced Pluripotent Stem Cell Market are Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation (Cellular Dynamics), Takara Bio Inc., Astellas Pharma Inc., Fate Therapeutics.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.